These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6866054)

  • 1. Glucocorticoid-induced osteoporosis.
    Baylink DJ
    N Engl J Med; 1983 Aug; 309(5):306-8. PubMed ID: 6866054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis, prevention and therapy of steroid osteoporosis].
    Dambacher MA; Olah AJ; Maurer H; Gampp R; Rüegsegger P
    Z Orthop Ihre Grenzgeb; 1990; 128(3):234-9. PubMed ID: 2144069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N; Muñoz-Torres M; Callejas-Rubio JL; Riera-Montes M
    J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and management of glucocorticoid-induced osteoporosis.
    Lane NE; Mroczkowski PJ; Hochberg MC
    Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of glucocorticoids on bone density.
    Rehman Q; Lane NE
    Med Pediatr Oncol; 2003 Sep; 41(3):212-6. PubMed ID: 12868121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Werth VP
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):84S-88S. PubMed ID: 9273946
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives on glucocorticoid-induced osteoporosis.
    Canalis E; Bilezikian JP; Angeli A; Giustina A
    Bone; 2004 Apr; 34(4):593-8. PubMed ID: 15050888
    [No Abstract]   [Full Text] [Related]  

  • 8. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect.
    Shah SK; Gecys GT
    J Am Osteopath Assoc; 2006 Nov; 106(11):653-7. PubMed ID: 17192452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract]   [Full Text] [Related]  

  • 15. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
    Ikeda S; Akahoshi S; Sakai A; Nakamura T
    Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of glucocorticoid-induced osteoporosis.
    Civitelli R; Ziambaras K
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):2-6. PubMed ID: 18791344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.